cas 2034325-39-6|| where to buy benzyl N-{2-oxo-2-[3-(pyrimidin-2-yloxy)piperidin-1-yl]ethyl}carbamate

Nom du produit:benzyl N-{2-oxo-2-[3-(pyrimidin-2-yloxy)piperidin-1-yl]ethyl}carbamate

IUPAC Name:benzyl N-{2-oxo-2-[3-(pyrimidin-2-yloxy)piperidin-1-yl]ethyl}carbamate

Unité d'emballage	Stock disponible	Prix($)	Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2034325-39-6 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:2034325-39-6; Formule moléculaire:C19H22N4O4; Point de fusion:-; Code SMILES:O=C(NCC(=O)N1CCCC(C1)OC1=NC=CC=N1)OCC1=CC=CC=C1; Densité:

: Numéro de catalogue:CM911517; Poids moléculaire:370.41; Point d'ébullition:; N° Mdl:; Stockage:

: Piperidines; Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.; Piperidine,Piperidine Price; if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.

: Pyrimidines; Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.